Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampoule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampoule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 10 million cells
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 25 million cells
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with cell population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell population frequency information
PyroCell® Monocyte Activation Test (MAT) Kit qualified for the monocyte activation test including 3 vials pooled PBMC (pMAT cells, 4 donors) as well as 3 vials of Cell Culture Medium Supplement for 3 x 96-well ELISA plates.
-
Cryopreservation of Peripheral Blood Mononuclear CellsDoes Not Alter Immune Cell Phenotype
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
-
B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial cells and Peripheral Blood Mononuclear Cells - Instructions for useProtocol to culture B-ALI NHBE cells with PBMCs
-
Validation of Th17 Cell Differentiation from Peripheral BloodLonza White Paper
-
siRNA Transfection Protocol for Blood LymphocytesInstructions of use for transfection of human peripheral blood lympohocytes with siRNA using the Nucleofector™ Technology
-
Transfection Protocol for Human T Cells (Stim.) - HT Nucleofector™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Tips For Optimizing Your CD8+ T Cell and Dendritic Cell Co-culturesA co-culture between matured dendritic cells (DCs) and CD8+ T cells isolated from Lonza cryopreserved human peripheral blood mononuclear cells (PBMCs; part nos. CC-2702 – CC-2705) and we present three major takeaways from this process that are critical for successful co-culture and end-point analysis for these two cell types
-
Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit